Bingfa Sun
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$4.3MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $4.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 18, 2023 | NIH | SBIR Phase I Discovery of GPR171 small molecule ligands for the treatment of chronic pain | $298K | CONFOMETRX, INC. |
| Jul 17, 2023 | NIH | SBIR Phase I Discovery of GPR75 small molecule ligands for the treatment of obesity | $303K | CONFOMETRX, INC. |
| Dec 17, 2020 | NIH | SBIR Phase II Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $676K | CONFOMETRX, INC. |
| Dec 20, 2019 | NIH | SBIR Phase II Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $676K | CONFOMETRX, INC. |
| Jan 4, 2019 | NIH | SBIR Phase II Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $676K | CONFOMETRX, INC. |
| Dec 7, 2017 | NIH | SBIR Phase II Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $381K | CONFOMETRX, INC. |
| Sep 12, 2017 | NIH | SBIR Phase II Structure-based Drug Discovery for the GLP-1 Receptor | $494K | CONFOMETRX, INC. |
| Dec 27, 2016 | NIH | SBIR Phase II Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $376K | CONFOMETRX, INC. |
| Jul 22, 2016 | NIH | SBIR Phase II Structure-based Drug Discovery for the GLP-1 Receptor | $467K | CONFOMETRX, INC. |
Peer ranks
Federal funding#342
Awards as PI#151
Patents#273
Companies
- CONFOMETRX, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.